• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Catalog Number ZIV6-35-125-6.0-60-PTX
Device Problem Occlusion Within Device (1423)
Patient Problems Reocclusion (1985); Claudication (2550)
Event Date 04/12/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).Device evaluation: this investigation deals with the restenosis of ziv6-35-125-6.0-60-ptx stent on the (b)(6) 2017.The device was implanted in the patient and is therefore unavailable for investigation.With the information provided a document based investigation was carried out.It is known the patient had the following pre-existing conditions: diabetes (type i) and hypercholesterolemia there is no evidence to suggest that this event did not occur, therefore the complaint is confirmed based on customer testimony.It was determined that there were no images available for review.Restenosis is a common adverse event of endovascular procedures and can be caused by injury to the vessel (e.G.During percutaneous transluminal angioplasty (pta) and/or stenting).Vessel injury provokes an inflammatory response that leads to (or amplifies) the restenosis process.It may be noted that surface of the zilver ptx stent is coated with the drug (paclitaxel) to help prevent subsequent restenosis of the artery.It can be therefore stated that it is very unlikely that the reported restenosis could have occurred due to zilver ptx malfunction; however as no imaging was available, a definitive root cause of this event cannot be determined at this time.It may be noted that as per the packaging insert worsened claudication & restenosis of the stented artery is a known potential adverse event associated with the placement of this device.Document review: the ziv6-35-125-6.0-60-ptx stent contains zilver ptx drug eluting stent zvsp6-125-6.0-60-is.Prior to distribution all zilver ptx devices are subject to visual inspection and functional checks to ensure device integrity.A review of the relevant manufacturing records revealed no discrepancies that could have contributed to this complaint.Summary: there is no evidence to suggest that this event did not occur, therefore the complaint is confirmed based on customer testimony.Pta was conducted as a result of this occurrence.The patient recovered.No other adverse events were reported.Complaints of this nature will continue to be monitored for any potential emerging trends.
 
Event Description
On (b)(6) 2012: two ptx stents were placed in the right sfa.(please refer to product information - notes for product and lot#s.) (b)(4).On (b)(6) 2016: restenosis was confirmed in the lesion.(worsen claudication were observed.) then, pta was performed and the patient recovered.(b)(4).On (b)(6) 2017: restenosis was confirmed in the lesion.(worsen claudication were observed.) then, pta was performed and the patient recovered.(b)(4).On (b)(6) 2017: restenosis was confirmed in the lesion.(worsen claudication were observed.) then, pta was performed and the patient recovered.(b)(4).On (b)(6) 2017: restenosis was confirmed in the lesion.(worsen claudication were observed.) then, pta was performed and the patient recovered.This investigation deals with the restenosis of ziv6-35-125-6.0-60-ptx stent of lot number c781079 on the (b)(6) 2017.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER PTX DRUG-ELUTING PERIPHERAL STENT
Type of Device
NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer Contact
michael galvin
o halloran road
national technology park
limerick 
061334440
MDR Report Key6916689
MDR Text Key88828307
Report Number3001845648-2017-00438
Device Sequence Number1
Product Code NIU
UDI-Device Identifier10827002513423
UDI-Public(01)10827002513423(17)140518(10)C781079
Combination Product (y/n)N
PMA/PMN Number
P100022
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 09/06/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberZIV6-35-125-6.0-60-PTX
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date10/04/2017
Event Location Hospital
Initial Date Manufacturer Received 09/06/2017
Initial Date FDA Received10/05/2017
Date Device Manufactured06/27/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-